Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Philips Respironics
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 40
Ability to provide consent
COPD diagnosis
Forced Expiratory Volume in one second (FEV1) \<55 and ≥ 25 percent of predicted value
Perceived Shortness of Breath via the Modified Medical Research Counsel Dyspnea questionnaire (rating of 2 or greater) (Appendix B)
Able to follow directions
Able to tolerate mild physical activity
Pursed Lip Breathing as standard of care
No evidence of bullous lung disease (with any bullae greater than 3cm in diameter) as confirmed by a CT scan within the past one year.
You may not be if
Subjects who are acutely ill, medically complicated or who are medically unstable as determined by the investigator.
Suffering from COPD exacerbation at time of enrollment or 60 days prior
Subjects who are not currently prescribed oxygen and manifest oxygen desaturation below 88% on the screening 6MWT
Subjects with heart disease or neuromuscular disease.
Subjects who are not prescribed short-acting bronchodilator medication
Patients who have experienced recent barotrauma or pneumothorax
Unstable angina or Myocardial Infarction during past month
Uncontrolled Hypertension (systolic blood pressure of \>180mmHg (millimeters of Mercury) and a diastolic \>100mmHg)
Heart Rate \>120 at rest
Subjects who have trouble coordinating their breathing with the device during the device training, or cannot tolerate the device mouthpiece resulting in leaks from the nasal cavity
Women of child-bearing potential (WOCP) who are pregnant, breast-feeding, or planning pregnancy during the course of the study. (WOCP must have a negative pregnancy test at every visit)
Clareo Health | Vitabreath Pilot in Chronic Obstructive Pulmonary Disease (COPD) Patients
